Diagnosis and treatment of upper respiratory tract infections in the primary care setting

Clinical Therapeutics

Volumn 23, Issue 10, 2001, Pages 1683-1706

  Fendrick, A Mark ^a,f   Saint, Sanjay ^a   Brook, Itzhak ^b   Jacobs, Michael R ^c   Pelton, Stephen ^d   Sethi, Sanjay ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Acute exacerbation of chronic bronchitis; Acute otitis media; Antimicrobial resistance; Respiratory tract infections; Sinusitis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; LEVOFLOXACIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC BRONCHITIS; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; HAEMOPHILUS INFLUENZAE; HUMAN; MEDICAL INFORMATION; MORAXELLA CATARRHALIS; OTITIS MEDIA; PHARMACODYNAMICS; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RHINOSINUSITIS; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION;

EID: 0035166524     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80137-5     Document Type: Article

References (73)

1. Trends in antimicrobial drug prescribing among office-based physicians in the United States
2. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns and antimicrobial management
3. Resistant pneumococci: Protecting patients through judicious use of antibiotics
4. The crisis in antibiotic resistance
5. Epidemiology of drug resistance: Implications for a post-antimicrobial era
6. Antimicrobial use for pediatric upper respiratory infections: Reported practice, actual practice, and parent beliefs
7. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections
8. Upper respiratory tract infections in family practice
9. Etiology and management of infections in chronic obstructive pulmonary disease
10. Acute suppurative otitis media in children. Diversity of clinical diagnostic criteria
11. Computed tomographic study of the common cold
12. Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination
13. Diagnosing acute maxillary sinusitis in primary care: A comparison of ultrasound, clinical examination and radiography
14. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae
15. Streptococcus pneumoniae colonization in the young child: Association with OM and resistance to penicillin
16. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
17. Bacteriologic and clinical efficacy of amoxicillin/clavulanate versus azithromycin in acute otitis media
18. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
19. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia
20. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya
21. Drug-resistant Streptococcus pneumoniae: Rational antibiotic choices
22. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to oral agents: Results of a 1998 US outpatient surveillance study
23. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
24. Acute otitis media in the 1990s: The impact of antibiotic resistance
25. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
26. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
27. Antibiotic availability and use: Consequences to man and his environment
28. Antibiotic resistance: An ecological imbalance
29. Current attitudes regarding use of antimicrobial agents: Results from physicians' and parents' focus group discussions
30. Cultural and economic factors that (mis)shape antibiotic use: The nonpharmacologic basis of therapeutics
31. The effect of a community intervention trial on parental knowledge and awareness of antibiotic resistance and appropriate antibiotic use in children
32. Epidemiology and treatment of chronic bronchitis and its exacerbations
33. Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age
34. Infections of the upper and lower respiratory tract
35. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis
36. Pneumococcal macrolide resistance - Myth or reality?
37. Antibiotic kinetics and dynamics for the clinician
38. Chronic obstructive pulmonary disease
39. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
40. Treatment cost of acute exacerbations of chronic bronchitis
41. Infectious exacerbations of chronic bronchitis: Diagnosis and management
42. Antibiotic therapy of exacerbations of chronic bronchitis
43. Antibiotics in chronic obstructive pulmonary disease exacerbations: A meta-analysis
44. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease
45. Recommendations on the management of chronic bronchitis: A practical guide for Canadian physicians
46. Bacterial infection in chronic obstructive pulmonary disease
47. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD
48. Acute exacerbation of COPD. Factors associated with poor treatment outcome
49. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis
50. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: A prospective, cohort study
51. How should relative risk estimates for acute otitis media in children aged less than 2 years be perceived?
52. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children
53. Clinical significance of resistant organisms in otitis media
54. Acute otitis media. Part 1: Improving diagnostic accuracy
55. Nasopharyngeal colonization with pathogens causing otitis media: How does this information help us?
56. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome
57. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media
58. Efficacy of a heptavalent pneumococcal conjugate vaccine (PncCRM) against serotype-specific, culture-confirmed pneumococcal acute otitis media in infants and children
59. Pharmacokinetics and pharmacodynamics of new and old antimicrobial agents for acute otitis media
60. Adult rhinosinusitis defined
61. Infectious rhinosinusitis in adults: Classification, etiology, and management
62. Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis: Summary of the Agency for Health Care Policy and Research evidence-based report
63. Bacteriology of chronic maxillary sinusitis in adults
64. Antimicrobial management of chronic sinusitis in children
65. The role of anaerobic bacteria in recurrent episodes of sinusitis and tonsillitis
66. Prevalence of beta-lactamase-producing bacteria in chronic suppurative otitis media
67. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection
68. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: A fifteen-year experience at the University of Virginia and review of other selected studies